Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Feb;105(2):441–447. doi: 10.1111/j.1476-5381.1992.tb14272.x

Pharmacological characterization of a receptor for calcitonin gene-related peptide on rat, L6 myocytes.

D R Poyner 1, D P Andrew 1, D Brown 1, C Bose 1, M R Hanley 1
PMCID: PMC1908676  PMID: 1313730

Abstract

1 The L6 myocyte cell line expresses high affinity receptors for calcitonin gene-related peptide (CGRP) which are coupled to activation of adenylyl cyclase. The biochemical pharmacology of these receptors has been examined by radioligand binding or adenosine 3':5'-cyclic monophosphate (cyclic AMP) accumulation. 2 In intact cells at 37 degrees C, human and rat alpha- and beta-CGRP all activated adenylyl cyclase with EC50s of about 1.5 nM. A number of CGRP analogues containing up to five amino acid substitutions showed similar potencies. In membrane binding studies at 22 degrees C in 1 mM Mg2+, the above all bound to a single site with IC50s of 0.1-0.4 nM. 3 The fragment CGRP(8-37) acted as a competitive antagonist of CGRP stimulation of adenylyl cyclase with a calculated Kd of 5 nM. The Kd determined in membrane binding assays was lower (0.5 nM). 4 The N-terminal extended human alpha-CGRP analogue Tyro-CGRP activated adenylyl cyclase and inhibited [125I]-iodohistidyl-CGRP binding less potently than human alpha-CGRP (EC50 for cyclase = 12 nM, IC50 for binding = 4 nM). 5 The pharmacological profile of the L6 CGRP receptor suggests that it most closely resembles sites on skeletal muscle, cardiac myocytes and hepatocytes. The L6 cell line should be a stable homogeneous model system in which to study CGRP mechanisms and pharmacology.

Full text

PDF
441

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aceves J., Mariscal S., Morrison K. E., Young J. M. The binding of doxepin to histamine H1-receptors in guinea-pig and rat brain. Br J Pharmacol. 1985 Feb;84(2):417–424. doi: 10.1111/j.1476-5381.1985.tb12925.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brain S. D., Williams T. J., Tippins J. R., Morris H. R., MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature. 1985 Jan 3;313(5997):54–56. doi: 10.1038/313054a0. [DOI] [PubMed] [Google Scholar]
  3. Chakder S., Rattan S. [Tyr0]-calcitonin gene-related peptide 28-37 (rat) as a putative antagonist of calcitonin gene-related peptide responses on opossum internal anal sphincter smooth muscle. J Pharmacol Exp Ther. 1990 Apr;253(1):200–206. [PubMed] [Google Scholar]
  4. Chiba T., Yamaguchi A., Yamatani T., Nakamura A., Morishita T., Inui T., Fukase M., Noda T., Fujita T. Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am J Physiol. 1989 Feb;256(2 Pt 1):E331–E335. doi: 10.1152/ajpendo.1989.256.2.E331. [DOI] [PubMed] [Google Scholar]
  5. Cooper G. J., Leighton B., Dimitriadis G. D., Parry-Billings M., Kowalchuk J. M., Howland K., Rothbard J. B., Willis A. C., Reid K. B. Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7763–7766. doi: 10.1073/pnas.85.20.7763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dennis T., Fournier A., St Pierre S., Quirion R. Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J Pharmacol Exp Ther. 1989 Nov;251(2):718–725. [PubMed] [Google Scholar]
  7. Fontaine B., Klarsfeld A., Hökfelt T., Changeux J. P. Calcitonin gene-related peptide, a peptide present in spinal cord motoneurons, increases the number of acetylcholine receptors in primary cultures of chick embryo myotubes. Neurosci Lett. 1986 Oct 30;71(1):59–65. doi: 10.1016/0304-3940(86)90257-0. [DOI] [PubMed] [Google Scholar]
  8. Gardiner S. M., Compton A. M., Kemp P. A., Bennett T., Bose C., Foulkes R., Hughes B. Antagonistic effect of human alpha-CGRP [8-37] on the in vivo regional haemodynamic actions of human alpha-CGRP. Biochem Biophys Res Commun. 1990 Sep 28;171(3):938–943. doi: 10.1016/0006-291x(90)90774-h. [DOI] [PubMed] [Google Scholar]
  9. Gilman A. G. A protein binding assay for adenosine 3':5'-cyclic monophosphate. Proc Natl Acad Sci U S A. 1970 Sep;67(1):305–312. doi: 10.1073/pnas.67.1.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Goodman E. C., Iversen L. L. Calcitonin gene-related peptide: novel neuropeptide. Life Sci. 1986 Jun 16;38(24):2169–2178. doi: 10.1016/0024-3205(86)90568-0. [DOI] [PubMed] [Google Scholar]
  11. Greenberg B., Rhoden K., Barnes P. Calcitonin gene-related peptide (CGRP) is a potent non-endothelium-dependent inhibitor of coronary vasomotor tone. Br J Pharmacol. 1987 Dec;92(4):789–794. doi: 10.1111/j.1476-5381.1987.tb11382.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Haegerstrand A., Dalsgaard C. J., Jonzon B., Larsson O., Nilsson J. Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. Proc Natl Acad Sci U S A. 1990 May;87(9):3299–3303. doi: 10.1073/pnas.87.9.3299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Han S. P., Naes L., Westfall T. C. Inhibition of periarterial nerve stimulation-induced vasodilation of the mesenteric arterial bed by CGRP (8-37) and CGRP receptor desensitization. Biochem Biophys Res Commun. 1990 Apr 30;168(2):786–791. doi: 10.1016/0006-291x(90)92390-l. [DOI] [PubMed] [Google Scholar]
  14. Hanley M. R. Analysis of receptor-coupled events in neuropeptide action using clonal cell lines. Prog Brain Res. 1987;72:189–196. doi: 10.1016/s0079-6123(08)60207-1. [DOI] [PubMed] [Google Scholar]
  15. Hothersall J. S., Muirhead R. P., Wimalawansa S. The effect of amylin and calcitonin gene-related peptide on insulin-stimulated glucose transport in the diaphragm. Biochem Biophys Res Commun. 1990 Jun 15;169(2):451–454. doi: 10.1016/0006-291x(90)90352-n. [DOI] [PubMed] [Google Scholar]
  16. Hulme E. C., Berrie C. P., Birdsall N. J., Jameson M., Stockton J. M. Regulation of muscarinic agonist binding by cations and guanine nucleotides. Eur J Pharmacol. 1983 Oct 14;94(1-2):59–72. doi: 10.1016/0014-2999(83)90442-9. [DOI] [PubMed] [Google Scholar]
  17. Jackson T. R., Hanley M. R. Tumor promoter 12-O-tetradecanoylphorbol 13-acetate inhibits mas/angiotensin receptor-stimulated inositol phosphate production and intracellular Ca2+ elevation in the 401L-C3 neuronal cell line. FEBS Lett. 1989 Jul 17;251(1-2):27–30. doi: 10.1016/0014-5793(89)81422-x. [DOI] [PubMed] [Google Scholar]
  18. Kreutter D., Orena S. J., Andrews K. M. Suppression of insulin-stimulated glucose transport in L6 myocytes by calcitonin gene-related peptide. Biochem Biophys Res Commun. 1989 Oct 16;164(1):461–467. doi: 10.1016/0006-291x(89)91742-7. [DOI] [PubMed] [Google Scholar]
  19. Laufer R., Changeux J. P. Calcitonin gene-related peptide elevates cyclic AMP levels in chick skeletal muscle: possible neurotrophic role for a coexisting neuronal messenger. EMBO J. 1987 Apr;6(4):901–906. doi: 10.1002/j.1460-2075.1987.tb04836.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Leighton B., Cooper G. J. Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature. 1988 Oct 13;335(6191):632–635. doi: 10.1038/335632a0. [DOI] [PubMed] [Google Scholar]
  21. Maggi C. A., Rovero P., Giuliani S., Evangelista S., Regoli D., Meli A. Biological activity of N-terminal fragments of calcitonin gene-related peptide. Eur J Pharmacol. 1990 Apr 10;179(1-2):217–219. doi: 10.1016/0014-2999(90)90422-3. [DOI] [PubMed] [Google Scholar]
  22. Maton P. N., Sutliff V. E., Zhou Z. C., Collins S. M., Gardner J. D., Jensen R. T. Characterization of receptors for calcitonin gene-related peptide on gastric smooth muscle cells. Am J Physiol. 1988 Jun;254(6 Pt 1):G789–G794. doi: 10.1152/ajpgi.1988.254.6.G789. [DOI] [PubMed] [Google Scholar]
  23. Mendoza-Hernández G., López-Solache I., Rendón J. L., Díaz-Sánchez V., Díaz-Zagoya J. C. 17 beta-hydroxysteroid dehydrogenase activity in canine pancreas. Biochem Biophys Res Commun. 1988 Apr 15;152(1):376–382. doi: 10.1016/s0006-291x(88)80724-1. [DOI] [PubMed] [Google Scholar]
  24. Miles K., Greengard P., Huganir R. L. Calcitonin gene-related peptide regulates phosphorylation of the nicotinic acetylcholine receptor in rat myotubes. Neuron. 1989 May;2(5):1517–1524. doi: 10.1016/0896-6273(89)90198-0. [DOI] [PubMed] [Google Scholar]
  25. Morishita T., Yamaguchi A., Fujita T., Chiba T. Activation of adenylate cyclase by islet amyloid polypeptide with COOH-terminal amide via calcitonin gene-related peptide receptors on rat liver plasma membranes. Diabetes. 1990 Jul;39(7):875–877. doi: 10.2337/diabetes.39.7.875. [DOI] [PubMed] [Google Scholar]
  26. Mulle C., Benoit P., Pinset C., Roa M., Changeux J. P. Calcitonin gene-related peptide enhances the rate of desensitization of the nicotinic acetylcholine receptor in cultured mouse muscle cells. Proc Natl Acad Sci U S A. 1988 Aug;85(15):5728–5732. doi: 10.1073/pnas.85.15.5728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. New H. V., Mudge A. W. Calcitonin gene-related peptide regulates muscle acetylcholine receptor synthesis. 1986 Oct 30-Nov 5Nature. 323(6091):809–811. doi: 10.1038/323809a0. [DOI] [PubMed] [Google Scholar]
  28. Nishi M., Sanke T., Nagamatsu S., Bell G. I., Steiner D. F. Islet amyloid polypeptide. A new beta cell secretory product related to islet amyloid deposits. J Biol Chem. 1990 Mar 15;265(8):4173–4176. [PubMed] [Google Scholar]
  29. Ohsawa H., Kanatsuka A., Yamaguchi T., Makino H., Yoshida S. Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets. Biochem Biophys Res Commun. 1989 Apr 28;160(2):961–967. doi: 10.1016/0006-291x(89)92529-1. [DOI] [PubMed] [Google Scholar]
  30. Yamaguchi A., Chiba T., Yamatani T., Inui T., Morishita T., Nakamura A., Kadowaki S., Fukase M., Fujita T. Calcitonin gene-related peptide stimulates adenylate cyclase activation via a guanine nucleotide-dependent process in rat liver plasma membranes. Endocrinology. 1988 Nov;123(5):2591–2596. doi: 10.1210/endo-123-5-2591. [DOI] [PubMed] [Google Scholar]
  31. Yoshizaki H., Takamiya M., Okada T. Characterization of picomolar affinity binding sites for [125I]-human calcitonin gene-related peptide in rat brain and heart. Biochem Biophys Res Commun. 1987 Jul 31;146(2):443–451. doi: 10.1016/0006-291x(87)90549-3. [DOI] [PubMed] [Google Scholar]
  32. Zaidi M., Brain S. D., Tippins J. R., Di Marzo V., Moonga B. S., Chambers T. J., Morris H. R., MacIntyre I. Structure-activity relationship of human calcitonin-gene-related peptide. Biochem J. 1990 Aug 1;269(3):775–780. doi: 10.1042/bj2690775. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES